AHA/CHF Congenital Heart Defect Research Awards
Forecasted
The AHA/CHF Congenital Heart Defect Research Awards fund innovative research on the prevention, diagnosis, and treatment of congenital heart defects, supported by The Children's Heart Foundation.
Funder: The Children's Heart Foundation
Due Dates (Anticipated): February 2027 (Full application deadline, projected)
Funding Amounts: Recent cycles awarded $625,000–$1.3M total per round; typical awards support several predoctoral/postdoctoral fellows annually.
Summary: Supports research advancing the prevention, diagnosis, and treatment of congenital heart defects through a partnership with the American Heart Association.
Description
The AHA/CHF Congenital Heart Defect Research Awards are a collaborative initiative between The Children's Heart Foundation and the American Heart Association. The program funds investigators conducting research that advances the prevention, diagnosis, and treatment of congenital heart defects (CHDs). These awards are designed to foster innovative scientific discoveries that improve outcomes for children born with congenital heart conditions. Funding is primarily targeted toward predoctoral and postdoctoral fellows engaged in basic, clinical, population, or translational research directly related to CHDs.
